Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycle

A method of non-continuous administration of a pharmaceutical to a human female for a condition associated with the female's menstrual cycle, comprising the steps of:

• a) ascertaining a number of days in the female's menstrual cycle;
• b) orally administering a daily first dosage, starting on the first day of the female's menstrual cycle and continuing the daily oral administrations of said first dosage for a first dosage period;
• and
• c) orally administering a daily second dosage, starting on the day after the last daily first dosage was administered and continuing the daily oral administration of said second dosage for a second dosage period or until the onset of menses;
• wherein either (i) said first dosage is a placebo and said second dosage is said pharmaceutical, and said second dosage period is a selected number of days to administer said pharmaceutical for effective treatment of said condition and said first dosage period is determined by subtracting the selected number of days from the number of days in the female's menstrual cycle;
• or (ii) said first dosage is said pharmaceutical and said second dosage is a placebo, and said first dosage period is a selected number of days to administer said pharmaceutical for effective treatment of said condition and said second dosage period is determined by subtracting the selected number of days from the number of days in the female's menstrual cycle;
• and
• wherein the first dosage and the second dosage administered during said menstrual cycle are selected from a single package.